| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |